Catalyst Pharmaceutical Inc.
Symbol: CPRX (NASDAQ)
21.03
▲ (0.91%) 0.190
Company Description:
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
Key Stats
- Today's Open: $20.74
- Today's High: $21.575
- Today's Low: $20.749
- Today's Volume: 1.07M
- Yesterday Close: $20.84
- Yesterday High: $21.05
- Yesterday Low: $20.12
- Yesterday Volume: 1.53M
- Last Min Volume: 0
- Last Min High: $21.03
- Last Min Low: $21.03
- Last Min VWAP: $0
Company Profile
- Name: Catalyst Pharmaceutical Inc.
- Website: https://www.catalystpharma.com
- Listed Date: 2006-11-08
- Location: CORAL GABLES, FL
- Market Status: Active
- CIK Number: 0001369568
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.55B
- Round Lot: 100
- Outstanding Shares: 122.39M
- Asset Type: CS
RECENT FILINGS FOR CPRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 8-K | View |
| 2025-09-10 | 4 | View |
| 2025-09-08 | 144 | View |
| 2025-09-05 | 4 | View |
| 2025-09-04 | 144 | View |
| 2025-09-03 | 144 | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 8-K/A | View |
| 2025-08-27 | 144 | View |
| 2025-08-26 | 144 | View |
| 2025-08-26 | 144 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-08 | 3 | View |
| 2025-08-07 | 8-K | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-04 | 8-K | View |
| 2025-06-12 | 4 | View |
Latest News on CPRX